Home›Stock Screener›Kobo Biotech›Financial Statements

Kobo Biotech Complete Financial Statements

1 Years of Data
2015 - 2015

In FYNone, Kobo Biotech (KOBO) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of -34.0% and ROE of -66.0%. Full financial statements from FY2015 to FY2015 (1 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see KOBO stock price BSE.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -33.98% 2015 data
EBITDA Margin -0.97% 2015 data
Operating Margin -1.00% 2015 data
Return on Assets -8.84% 2015 data
Return on Equity -66.04% 2015 data

Balance Sheet Ratios

Current Ratio 3.67 2015 data
Debt to Equity 7.47 2015 data
Equity Ratio 13.38% 2015 data
Asset Turnover 0.26 2015 data

KOBO Revenue, Net Profit & EBITDA — Year-on-Year Growth

KOBO YoY (March 2015 vs Period) — revenue -100.0%, net profit +100.0%, EBITDA +100.0%, expenses -100.0%. Explore KOBO Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year

KOBO Income Statement — Revenue, EBITDA & Net Profit

Kobo Biotech revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin -34.0%. Review KOBO earnings valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2015
Revenue 0 103
Expenses 0 104
EBITDA 0 -1
Operating Profit Margin % 0.00% -1.00%
Depreciation 0 10
Interest 0 24
Profit Before Tax 0 -34
Tax 0 1
Net Profit 0 -35
Earnings Per Share (₹) 0.00 -15.47

KOBO Balance Sheet — Assets, Liabilities & Shareholders' Equity

KOBO total assets ₹396 Cr, total equity ₹53 Cr, total liabilities ₹396 Cr (2015) — ROE -66.0%.

Years Annual Data ₹ Crores
Particulars 2015
ASSETS
Total Assets 396
Current Assets 290
Fixed Assets 104
Capital Work in Progress 2
Investments 0
Other Assets 290
LIABILITIES
Total Liabilities 396
Current Liabilities 79
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 53
Share Capital 23
Reserves & Surplus 31

KOBO Cash Flow Statement — Operating, Investing & Financing

Kobo Biotech operating cash flow ₹7 Cr, investing ₹-5 Cr, financing ₹-13 Cr, net cash flow ₹-11 Cr (2015).

Periods ₹ Crores
Particulars March 2015
Operating Activities 7
Investing Activities -5
Financing Activities -13
Net Cash Flow -11